Merck & Co Inc (NYSE:MRK)

74.60
Delayed Data
As of 4:00pm ET
 +1.14 / +1.55%
Today’s Change
56.26
Today|||52-Week Range
83.85
-2.37%
Year-to-Date

Today’s Trading

Previous close73.46
Today’s open73.70
Day’s range73.40 - 75.25
Volume18,398,386
Average volume (3 months)12,119,350
Market cap$189.1B
Data as of 4:00pm ET, 04/23/2019

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+7.87%
Earnings growth (next 5 years)+9.20%
Revenue growth (last year)+6.17%
P/E ratio32.2
Price/Sales4.82
Price/Book7.11

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.50+0.66%
PFEPfizer+0.44+1.13%
ABTAbbott Laboratories+1.59+2.13%
LLYEli Lilly and Co+2.02+1.75%
Data as of 4:02pm ET, 04/23/2019

Financials

Next reporting dateApril 30, 2019
EPS forecast (this quarter)$1.06
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts